COMBINED THERAPY: WHAT DOES ACAMPROSATE AND NALTREXONE COMBINATION TELL US?

Authors: FALK KIEFER1; KLAUS WIEDEMANN

Source: Alcohol and Alcoholism, Volume 39, Number 6, November 2004 , pp. 542-547(6)

Publisher: Oxford University Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aims: Relapse prevention treatment with both acamprosate and naltrexone has been shown to be efficacious in the treatment of alcoholism. Whereas both compounds act pharmacologically differently, there is up to now only limited evidence as to whether combined treatment is efficacious and pharmacologically safe. It remains to be answered whether data justify the combination of both drugs in clinical practice. Methods: Review of the three pre-clinical and four clinical studies that have been published to date on either combined tolerability or efficacy. Results: Data available up to now show no occurrence of severe adverse events during combined treatment. Diarrhoea and nausea were shown to be the most significant side-effects. Whereas pre-clinical studies regarding efficacy of combined treatment are not yet conclusive, clinical data show the superiority of combined treatment compared with both placebo and acamprosate monotherapy. The synergistic effect of combined treatment remained after 12 weeks of drug-free follow-up. Conclusions: The combination of acamprosate with naltrexone in a clinical sample seems to be efficacious and safe. Numerous alcohol dependent patients could benefit, particularly those that responded insufficiently on monotherapeutic treatment with either acamprosate or naltrexone.

Document Type: Research article

DOI: 10.1093/alcalc/agh093

Affiliations: 1: Author to whom correspondence should be addressed at: Department of Psychiatry and Psychotherapy, University Hospital of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany., Tel: +49 40 42803 5356, Fax: +49 40 42803 3417, Email: kiefer@uke.uni-ha

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$40.03 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A